$OSCR Cashflow Statement | Understand Stock

$OSCR

$31.35 +$0.25 (0.8%) Close

$OSCR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Deferred taxes
Net realized loss (gain) on sale of financial instruments
Loss on fair value of warrant liabilities
Depreciation and amortization expense
Amortization of debt issuance costs
Stock-based compensation expense
Net accretion of investments
Debt extinguishment loss
Non-cash inducement payment for convertible note conversion (Note 9)
Change in provision for credit losses
Changes in assets and liabilities:
(Increase) / decrease in:
Premiums and accounts receivable
Risk adjustment transfer receivable
Accrued investment income
Reinsurance recoverable
Other assets

Increase / (decrease) in:
Benefits payable
Unearned premiums
Premium deficiency reserve
Accounts payable and other liabilities
Reinsurance payable
Risk adjustment transfer payable
Net cash (used in) provided by operating activities
Cash Flows from Investing Activities:
Purchase of investments
Sale of investments
Maturity and paydowns of investments
Purchase of property, equipment and capitalized software
Change in restricted deposits
Other, net
Net cash (used in) provided by investing activities

Cash Flows from Financing Activities:
Proceeds from long-term debt
Payments of debt issuance costs
Inducement payment for convertible note conversion
Purchase of capped calls related to convertible notes
Tax payments related to net settlement of share-based awards
Proceeds from exercise of stock options
Proceeds from joint venture contribution
Debt prepayment
Debt extinguishment costs
Proceeds from IPO, net of underwriting discounts
Offering costs from IPO
Convertible preferred stock and call option issuances
Proceeds from exercise of warrants and call options
Stock repurchased
Net cash provided by financing activities

Increase (decrease) in cash, cash equivalents and restricted cash equivalents
Cash, cash equivalents, restricted cash and cash equivalents—beginning of period
Cash, cash equivalents, restricted cash and cash equivalents—end of period
Supplemental Disclosures:
Interest payments
Income tax payments
Non-Cash Investing and Financing Activities:
Conversion of redeemable convertible preferred stock to common stock upon initial public offering
Net exercise of preferred stock warrants to preferred stock upon initial public offering
Adjustment to fair value of preferred stock warrant liability upon initial public offering
Conversion of convertible notes into common stock (Note 9)
Cash and cash equivalents
Restricted cash and cash equivalents included in restricted deposits

Comments